Irinotecan (Camptosar, Pfizer; Campto, Yakult Honsha) is a drug used for the treatment of cancer.
Irinotecan prevents DNA from unwinding by inhibition of topoisomerase 1. In chemical terms, it is a semisynthetic analogue of the natural alkaloid camptothecin.
Its main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen FOLFIRI, which consists of infusional 5-fluorouracil, leucovorin, and irinotecan.
Irinotecan received accelerated approval by the U.S. Food and Drug Administration (FDA) in 1996 and full approval in 1998. During development, it was known as CPT-11.
This text uses material from Wikipedia, licensed under CC BY-SA
Sorry, no news articles match your request
About
Phys.org™ is a leading web-based science, research and technology news service which covers a full range of topics.
Phys.org is a part of Science X network. With a global reach of over 10 million monthly readers and featuring dedicated websites for science (Phys.org), technology (Tech Xplore) and medical research (Medical Xpress), the Science X network is one of the largest online communities for science-minded people.
Read moreIdentify the news topics you want to see and prioritize an order.
Science never stops. Get notified about trending stories.